A Study of Tarceva (Erlotinib) and Standard of Care Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Clinical Trial ID NCT00556322

PubWeight™ 9.74^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00556322

Top papers